Literature DB >> 21147772

Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation.

Beinan Liu1, Aileen Moloney, Sarah Meehan, Kyle Morris, Sally E Thomas, Louise C Serpell, Robert Hider, Stefan J Marciniak, David A Lomas, Damian C Crowther.   

Abstract

We have previously shown that overexpressing subunits of the iron-binding protein ferritin can rescue the toxicity of the amyloid β (Aβ) peptide in our Drosophila model system. These data point to an important pathogenic role for iron in Alzheimer disease. In this study, we have used an iron-selective chelating compound and RNAi-mediated knockdown of endogenous ferritin to further manipulate iron in the brain. We confirm that chelation of iron protects the fly from the harmful effects of Aβ. To understand the pathogenic mechanisms, we have used biophysical techniques to see how iron affects Aβ aggregation. We find that iron slows the progression of the Aβ peptide from an unstructured conformation to the ordered cross-β fibrils that are characteristic of amyloid. Finally, using mammalian cell culture systems, we have shown that iron specifically enhances Aβ toxicity but only if the metal is present throughout the aggregation process. These data support the hypothesis that iron delays the formation of well ordered aggregates of Aβ and so promotes its toxicity in Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21147772      PMCID: PMC3039358          DOI: 10.1074/jbc.M110.158980

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation.

Authors:  C Nilsberth; A Westlind-Danielsson; C B Eckman; M M Condron; K Axelman; C Forsell; C Stenh; J Luthman; D B Teplow; S G Younkin; J Näslund; L Lannfelt
Journal:  Nat Neurosci       Date:  2001-09       Impact factor: 24.884

2.  SCREENING FOR AMYLOID WITH THE THIOFLAVIN-T FLUORESCENT METHOD.

Authors:  D R ROGERS
Journal:  Am J Clin Pathol       Date:  1965-07       Impact factor: 2.493

Review 3.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

4.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

Authors:  M P Lambert; A K Barlow; B A Chromy; C Edwards; R Freed; M Liosatos; T E Morgan; I Rozovsky; B Trommer; K L Viola; P Wals; C Zhang; C E Finch; G A Krafft; W L Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

5.  Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease.

Authors:  D C Crowther; K J Kinghorn; E Miranda; R Page; J A Curry; F A I Duthie; D C Gubb; D A Lomas
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

Review 6.  Folding proteins in fatal ways.

Authors:  Dennis J Selkoe
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

Review 7.  Redox-active metals, oxidative stress, and Alzheimer's disease pathology.

Authors:  Xudong Huang; Robert D Moir; Rudolph E Tanzi; Ashley I Bush; Jack T Rogers
Journal:  Ann N Y Acad Sci       Date:  2004-03       Impact factor: 5.691

8.  The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds.

Authors:  Sean A Hudson; Heath Ecroyd; Tak W Kee; John A Carver
Journal:  FEBS J       Date:  2009-09-15       Impact factor: 5.542

9.  The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging.

Authors:  Luigi Zecca; Antonella Stroppolo; Alberto Gatti; Davide Tampellini; Marco Toscani; Mario Gallorini; Giuseppe Giaveri; Paolo Arosio; Paolo Santambrogio; Ruggero G Fariello; Erdem Karatekin; Mark H Kleinman; Nicholas Turro; Oleh Hornykiewicz; Fabio A Zucca
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

10.  Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's disease.

Authors:  Thomas Rival; Richard M Page; Dhianjali S Chandraratna; Timothy J Sendall; Edward Ryder; Beinan Liu; Huw Lewis; Thomas Rosahl; Robert Hider; L M Camargo; Mark S Shearman; Damian C Crowther; David A Lomas
Journal:  Eur J Neurosci       Date:  2009-03-23       Impact factor: 3.386

View more
  66 in total

Review 1.  Amyloid scaffolds as alternative chlorosomes.

Authors:  Rolando F Rengifo; Noel X Li; Anthony Sementilli; David G Lynn
Journal:  Org Biomol Chem       Date:  2017-08-30       Impact factor: 3.876

2.  Aβ association inhibition by transferrin.

Authors:  Annie V Raditsis; Julijana Milojevic; Giuseppe Melacini
Journal:  Biophys J       Date:  2013-07-16       Impact factor: 4.033

3.  Higher Hippocampal Mean Diffusivity Values in Asymptomatic Welders.

Authors:  Eun-Young Lee; Michael R Flynn; Guangwei Du; Mechelle M Lewis; Lan Kong; Jeff D Yanosky; Richard B Mailman; Xuemei Huang
Journal:  Toxicol Sci       Date:  2019-04-01       Impact factor: 4.849

4.  Lipocalin 2 modulates the cellular response to amyloid beta.

Authors:  S D Mesquita; A C Ferreira; A M Falcao; J C Sousa; T G Oliveira; M Correia-Neves; N Sousa; F Marques; J A Palha
Journal:  Cell Death Differ       Date:  2014-05-23       Impact factor: 15.828

Review 5.  Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim.

Authors:  Orly Weinreb; Silvia Mandel; Orit Bar-Am; Tamar Amit
Journal:  J Neural Transm (Vienna)       Date:  2011-03-01       Impact factor: 3.575

Review 6.  Treating Alzheimer's disease by targeting iron.

Authors:  Sara Nikseresht; Ashley I Bush; Scott Ayton
Journal:  Br J Pharmacol       Date:  2019-02-11       Impact factor: 8.739

Review 7.  Contribution of the oligodendrocyte lineage to CNS repair and neurodegenerative pathologies.

Authors:  Reshmi Tognatta; Robert H Miller
Journal:  Neuropharmacology       Date:  2016-04-21       Impact factor: 5.250

8.  Protein Phosphatase 2A as a Drug Target in the Treatment of Cancer and Alzheimer's Disease.

Authors:  Hui Wei; Hui-Liang Zhang; Jia-Zhao Xie; Dong-Li Meng; Xiao-Chuan Wang; Dan Ke; Ji Zeng; Rong Liu
Journal:  Curr Med Sci       Date:  2020-03-13

Review 9.  Modeling the complex pathology of Alzheimer's disease in Drosophila.

Authors:  Pedro Fernandez-Funez; Lorena de Mena; Diego E Rincon-Limas
Journal:  Exp Neurol       Date:  2015-05-27       Impact factor: 5.330

Review 10.  Biometals and their therapeutic implications in Alzheimer's disease.

Authors:  Scott Ayton; Peng Lei; Ashley I Bush
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.